MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB)

CUSIP: 59064R109

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, no par value
Shares outstanding
5,555,932
Total 13F shares
5,194,339
Share change
+42,417
Total reported value
$489,420,814
Price per share
$94.22
Number of holders
154
Value change
+$3,151,880
Number of buys
69
Number of sells
73

Quarterly Holders Quick Answers

What is CUSIP 59064R109?
CUSIP 59064R109 identifies MLAB - MESA LABORATORIES INC /CO/ - Common Stock, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of MLAB - MESA LABORATORIES INC /CO/ - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
15%
827,616
$98,204,918 31 Mar 2025
13F
Conestoga Capital Advisors, LLC
13D/G 13F
Conestoga Capital Advisors · Company
11%
618,111
$71,997,569 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
6.9%
384,613
$45,638,179 31 Mar 2025
13F
ROYCE & ASSOCIATES LP
13F 13D/G
Company
5%
from 13D/G
271,118
$32,170,862 31 Mar 2025
RAYMOND JAMES FINANCIAL INC
13F
Company
4.8%
264,013
$31,327,840 31 Mar 2025
13F
Ranger Investment Management, L.P.
13F
Company
4.2%
230,988
$27,409,036 31 Mar 2025
13F
STATE STREET CORP
13F
Company
4%
219,543
$26,050,972 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
3.9%
216,290
$25,665,044 31 Mar 2025
13F
GENEVA CAPITAL MANAGEMENT LLC
13F
Company
3.4%
189,312
$22,463,729 31 Mar 2025
13F
AMERIPRISE FINANCIAL INC
13F
Company
3%
166,768
$19,788,690 31 Mar 2025
13F
GLENMEDE TRUST CO NA
13F
Company
2.6%
146,544
$17,388,910 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.5%
137,516
$16,321,502 31 Mar 2025
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
2%
113,271
$13,440,737 31 Mar 2025
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
2%
111,247
$13,200,785 31 Mar 2025
13F
Russell Investments Group, Ltd.
13F
Company
1.6%
87,056
$10,330,171 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
1.5%
82,444
$9,782,806 31 Mar 2025
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.5%
80,744
$9,654,297 31 Mar 2025
13F
Select Equity Group, L.P.
13F
Company
1.3%
73,897
$8,768,618 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.2%
67,307
$7,986,650 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
1.2%
65,464
$7,767,958 31 Mar 2025
13F
John Bradley Schmieder
3/4/5
Director
class O/S missing
62,760
$7,051,714 14 Sep 2023
Bank of New York Mellon Corp
13F
Company
0.99%
54,767
$6,498,647 31 Mar 2025
13F
COMERICA BANK
13F
Company
0.8%
44,285
$5,254,809 31 Mar 2025
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.79%
43,659
$5,180,575 31 Mar 2025
13F
Meros Investment Management, LP
13F
Company
0.58%
31,964
$3,792,848 31 Mar 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.55%
30,772
$3,652,000 31 Mar 2025
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.54%
30,019
$3,561,978 31 Mar 2025
13F
DIAMOND HILL CAPITAL MANAGEMENT INC
13F
Company
0.53%
29,458
$3,495,486 31 Mar 2025
13F
MESA LABORATORIES INC /CO/
3/4/5
Director
mixed-class rows
29,818
mixed-class rows
$3,350,351 15 Jun 2022
Evan Guillemin
3/4/5
Director
mixed-class rows
29,297
mixed-class rows
$3,281,699 01 Sep 2022
BBR PARTNERS, LLC
13F
Company
0.5%
27,595
$3,274,423 31 Mar 2025
13F
UBS Group AG
13F
Company
0.49%
27,387
$3,249,741 31 Mar 2025
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.49%
27,375
$3,248,318 31 Mar 2025
13F
CRAWFORD INVESTMENT COUNSEL INC
13F
Company
0.47%
26,200
$3,108,892 31 Mar 2025
13F
John Sakys
3/4/5
CFO
mixed-class rows
49,530
mixed-class rows
$2,566,577 -$62,350 21 Jun 2025
SEGALL BRYANT & HAMILL, LLC
13F
Company
0.36%
20,010
$2,374,387 31 Mar 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.36%
19,977
$2,370,470 31 Mar 2025
13F
KING LUTHER CAPITAL MANAGEMENT CORP
13F
Company
0.36%
19,921
$2,363,826 31 Mar 2025
13F
Nuveen, LLC
13F
Company
0.35%
19,424
$2,304,851 31 Mar 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
0.34%
19,058
$2,261,478 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.32%
17,929
$2,127,457 31 Mar 2025
13F
PUBLIC SECTOR PENSION INVESTMENT BOARD
13F
Company
0.31%
17,256
$2,047,597 31 Mar 2025
13F
Keeley-Teton Advisors, LLC
13F
Company
0.28%
15,678
$1,860,351 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.28%
15,334
$1,819,535 31 Mar 2025
13F
Legal & General Group Plc
13F
Company
0.25%
13,911
$1,650,679 31 Mar 2025
13F
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
13F
Company
0.25%
13,722
$1,628,253 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.25%
13,628
$1,617,074 31 Mar 2025
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.24%
13,237
$1,570,702 31 Mar 2025
13F
HERALD INVESTMENT MANAGEMENT Ltd
13F
Company
0.22%
12,500
$1,483,250 31 Mar 2025
13F
LAZARD ASSET MANAGEMENT LLC
13F
Company
0.2%
11,360
$1,347,000 31 Mar 2025
13F

Institutional Holders of MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB) as of Q2 2025

As of 30 Jun 2025, MESA LABORATORIES INC /CO/ - Common Stock, no par value (MLAB) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,194,339 shares. The largest 10 holders included BlackRock, Inc., Conestoga Capital Advisors, LLC, VANGUARD GROUP INC, ROYCE & ASSOCIATES LP, MORGAN STANLEY, Ranger Investment Management, L.P., STATE STREET CORP, GENEVA CAPITAL MANAGEMENT LLC, RAYMOND JAMES FINANCIAL INC, and Glenmede Investment Management, LP. This page lists 153 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
151
Q2 2025 holders
154
Holder diff
3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .